Pathological microscopes are utilized in the diagnostic centers for diagnosis of infectious and chronic diseases. More precisely, it is used to examine cells and body fluids in the laboratory and assess, type, quantity, and characteristics of the blood cells.
The growing use of pathological microscopes in the drug discovery, increasing prevalence of the infectious and chronic diseases, growing automation in the laboratories and growth in number of private and public diagnostic centers are major drivers driving the market growth. Though, unfavourable reimbursement policies and the high cost associated with the microscopes constrain growth of the market. Segment Overview
Growing use of pathological microscopes in the drug discovery is anticipated to drive growth of market. Pharmaceutical industry is observing rapid change in the technology due to growing research and development activities lead by the private as well as the public partners. Majority of players in pharmaceutical market are capitalizing huge money in development of the new drugs. With growing research and development activities, use and demand for the advanced instruments including pathological microscopes in pharmaceutical industry are growing.
Growing pathological microscopes in the drug discovery is the primary factor accelerating growth of market. According to International Federation of the Pharmaceutical Manufacturers and Associations, in 2015, global pharmaceutical industry expended over USD 149.8 billion on the research and development activities. Furthermore, rising prevalence of the chronic and infectious diseases, growing automation in laboratories fuelled the growth of market. Moreover, growth in number of public and private diagnostic facilities are likely to upkeep the market growth. On the other hand, high costs associated with the microscopes and unfavourable reimbursement policies is expected to hamper market growth.Regional Overview
The North America is projected to dominate global pathological microscopes market over the forecast period. This is accredited to developed healthcare infrastructure, rising number of the academic institutes, and growing research and development activities in this region.
The market for the pathological microscopes in the Europe is anticipated to be second-largest during forecast period, owing to the factors such as support provided by the government bodies for healthcare sector, growths in life science sector and swelling research and development activities. Moreover, companies operating in market are mainly concentrating on the mergers and acquisition, which is anticipated to support the market growth.
Asia-Pacific is projected to be fastest-growing market due to developing healthcare infrastructure and the growing disposable income. Additionally, growing healthcare infrastructure has augmented the number of various research activities in the region.Competitor overview
In August 2018, company, Nikon Corporation announced launch of A1R HD25 confocal microscope. This microscope with high resolution and the high-throughput and is recognised as world's largest twenty five mm field view confocal microscope.
In June 2018, company Olympus Corporation announced its partnership with the MedTech innovator to increase the clinical outcomes and also to reduce the overall cost coupled with improved quality.
In March 2017, company Hitachi High-Technologies Corporation opened the High-Tech Science Park Shanghai Lab in the city Shanghai. This helped company develop and sell the analytical instruments in Chinese market.Key Players
- Nikon Corporation
- Leica Biosystems Nussloch GmbH
- Olympus Corporation
- ZEISS International
- Sakura Finetek USA, Inc.
- Celestron, LLC.
- Labomed Inc.
- Hitachi High-Technologies Corporation
- Bruker Corporation
- Euromex Microscopen BV
- Compound Microscope
- Electron Microscope
- Optical Microscope
- Digital Microscope
- Fluorescence Microscope
By End User
- Pathology & Diagnostic laboratories
- Forensic Laboratories
- Hospitals & Clinics
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- Rest of LAMEA